Transferrin-Bearing, Zein-Based Hybrid Lipid Nanoparticles for Drug and Gene Delivery to Prostate Cancer Cells
Authors:
- Khadeejah MaeyoufKMKhadeejah Maeyouf
- Intouch SakpakdeejaroenISIntouch Sakpakdeejaroen
- Sukrut SomaniSSSukrut Somani
- Jitkasem MeewanJMJitkasem Meewan
- Hawraa Ali-JermanHAHawraa Ali-Jerman
- Partha LaskarPLPartha Laskar
- Margaret MullinMMMargaret Mullin
- Graeme MacKenzieGMGraeme MacKenzie
- Rothwelle J. TateRTRothwelle J. Tate
- Christine DufèsChristine Dufès
Open Access
- 20 November 2023
- journal article
- research article
- Published by MDPI AG in Pharmaceutics
- Vol. 15 (11) , 2643
Abstract
Gene therapy holds great promise for treating prostate cancer unresponsive to conventional therapies. However, the lack of delivery systems that can transport therapeutic DNA and drugs while targeting tumors without harming healthy tissues presents a significant challenge. This study aimed to explore the potential of novel hybrid lipid nanoparticles, composed of biocompatible zein and conjugated to the cancer-targeting ligand transferrin. These nanoparticles were designed to entrap the anti-cancer drug docetaxel and carry plasmid DNA, with the objective of improving the delivery of therapeutic payloads to prostate cancer cells, thereby enhancing their anti-proliferative efficacy and gene expression levels. These transferrin-bearing, zein-based hybrid lipid nanoparticles efficiently entrapped docetaxel, leading to increased uptake by PC-3 and LNCaP cancer cells and significantly enhancing anti-proliferative efficacy at docetaxel concentrations exceeding 1 µg/mL. Furthermore, they demonstrated proficient DNA condensation, exceeding 80% at polymer–DNA weight ratios of 1500:1 and 2000:1. This resulted in increased gene expression across all tested cell lines, with the highest transfection levels up to 11-fold higher than those observed with controls, in LNCaP cells. These novel transferrin-bearing, zein-based hybrid lipid nanoparticles therefore exhibit promising potential as drug and gene delivery systems for prostate cancer therapy.Keywords
Funding Information
- Libyan Government (TU_9708, R463/0216, 16-1303)
- Thammasat University (TU_9708, R463/0216, 16-1303)
- Kuwait University (TU_9708, R463/0216, 16-1303)
- Vivensa Foundation (TU_9708, R463/0216, 16-1303)
- Worldwide Cancer Research (TU_9708, R463/0216, 16-1303)
This publication has 64 references indexed in Scilit:
- Ligand modified nanoparticles increases cell uptake, alters endocytosis and elevates glioma distribution and internalizationScientific Reports, 2013
- Fabrication and characterization of DNA-loaded zein nanospheresJournal of Nanobiotechnology, 2012
- Synthesis of Novel Biodegradable Methoxy Poly(ethylene glycol)–Zein Micelles for Effective Delivery of CurcuminMolecular Pharmaceutics, 2012
- The transferrin receptor and the targeted delivery of therapeutic agents against cancerBiochimica et Biophysica Acta (BBA) - General Subjects, 2012
- The mechanisms of drug release in poly(lactic-co-glycolic acid)-based drug delivery systems—A reviewInternational Journal of Pharmaceutics, 2011
- Recovery and Characterization of α-Zein from Corn Fermentation CoproductsJournal of Agricultural and Food Chemistry, 2011
- The Biodegradation of Zein In Vitro and In Vivo and its Application in ImplantsAAPS PharmSciTech, 2010
- Encapsulation of Essential Oils in Zein Nanospherical ParticlesJournal of Agricultural and Food Chemistry, 2005
- Preparation of zein microspheres conjugated with antitumor drugs available for selective cancer chemotherapy and development of a simple colorimetric determination of drugs in microspheres.Chemical and Pharmaceutical Bulletin, 1989
- Amino acid composition of zein molecular componentsPhytochemistry, 1977